Uneingeschränkter Zugang

Prevalence of class 1 and 2 integrons among the multidrug resistant uropathogenic strains of Escherichia coli


Zitieren

Figure 1

PCR analysis and restriction fragment length polymorphism analysis of PCR products of E. coli antibiotic resistance integrons. M: 100 bp ladder, Lane 1: positive control (491 bp), Lane 2: Class 1 integron (PCR product treated by HinfI, a 491 bp fragment), Lane 3: Class 1 integron (PCR product treated by RsaI, a 491 bp fragment), Lane 4: Class 2 integron (PCR product treated by HinfI, 300 and 191 bp fragments), Lane 5: Class 2 integron (PCR product treated by RsaI, 334 and 157 bp fragments).
PCR analysis and restriction fragment length polymorphism analysis of PCR products of E. coli antibiotic resistance integrons. M: 100 bp ladder, Lane 1: positive control (491 bp), Lane 2: Class 1 integron (PCR product treated by HinfI, a 491 bp fragment), Lane 3: Class 1 integron (PCR product treated by RsaI, a 491 bp fragment), Lane 4: Class 2 integron (PCR product treated by HinfI, 300 and 191 bp fragments), Lane 5: Class 2 integron (PCR product treated by RsaI, 334 and 157 bp fragments).

Association between antibiotic resistance and presence of integrons in E. coli isolates

AntibioticResistant int-positive

int-positive = Integron positive

(Number of isolates)
Resistant int-negative

int-negative = Integron negative

(Number of isolates)
Total number of isolatesAssociation with integron
Nitrofurantoin1910<0.12
Levofloxacin102434<0.59
Amikacin31215<0.22
Chloramphenicol41519<0.87
Gentamycin62026<0.72
Nalidixic acid155267<0.44
Ciprofloxacin102737<0.23
Norfloxacin92635<0.23
Ofloxacin92534<0.32
Tetracycline155671<0.35
Amoxicillin206888<0.97
Co-trimoxazole194968<0.048
Imipenem82129<0.93
Cephalexin164965<0.37
Ceftriaxone113445<0.76
Cefotaxime113546<0.77
Cephalothin124254<0.74
Ceftazidime62733<0.34
Ceftizoxime52227<0.74
eISSN:
1875-855X
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
6 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Gesundheitsfachberufe, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin